Forbes -
21 Mar 2016 20:12
In trading on Monday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 2.8% on the day. Components of that ETF showing particular strength include shares of Sarepta Therapeutics (SRPT), up about 18.2% and shares of Advaxis (ADXS), up about 13.7% on the day.
Share this Article
Comment on this Article
Please to comment